All In MedTech

Device Trial Radar · NCT02982174

Evaluation of the Signal to Noise Ratio at Various Retinal Layers

Evaluation of the Signal to Noise Ratio at Various Retinal Layers in Spectral Domain Optical Coherence Tomography (SD OCT) Compared to Swept Source Optical Coherence Tomography (SS OCT)

Last checked: Nov 20, 2026Latest source record: Jun 8, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

15

Actual

Start

Dec 2016

Primary completion

Dec 2016

Study completion Jan 2017

Sponsor

Lead sponsor
Topcon Medical Systems, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Dec 5, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Compare the signal to noise ratio of each device at various retinal layers.

Conditions

  • Healthy Eyes

Interventions

  • 3D OCT-1 MaestroDevice

    Image acquisition of the posterior surface of the eye

  • DRI OCT TritonDevice

    Image acquisition of the posterior surface of the eye

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Signal to noise ratio between SD OCT and SS OCTTime frame: 5 minutes

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Topcon Medical Systems Inc.

    Oakland, New Jersey

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.